Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 20/20 | 0.69 |
| ▸ | HTR2A | P28223 | 18/20 | 0.69 |
| ▸ | HTR2B | P41595 | 17/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | HTR6 | P50406 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7082972 | 0.85 | HTR2C (0.72) | HTR2CHTR2AHTR2BCYP1A2 | |
| SCHEMBL7082946 | 0.81 | HTR2C (1.00) | HTR2CHTR2AHTR2BCYP1A2CYP2C9 | |
| SCHEMBL7078894 | 0.81 | HTR2C (1.00) | HTR2CHTR2AHTR2BCYP1A2CYP2C9 | |
| SCHEMBL8116621 | 0.81 | HTR2C (1.00) | HTR2CHTR2AHTR2BCYP2C9HTR6 | |
| SCHEMBL7379147 | 0.81 | HTR2C (0.66) | HTR2CHTR2AHTR2BCYP1A2 | |
| SCHEMBL7084100 | 0.79 | HTR2C (0.78) | HTR2CHTR2AHTR2BCYP1A2CYP2C9 | |
| SCHEMBL15621810 | 0.79 | HTR2C (0.59) | HTR2CHTR2AHTR2BCYP1A2CYP2C9 | |
| SCHEMBL15621809 | 0.79 | HTR2C (0.59) | HTR2CHTR2AHTR2BCYP1A2CYP2C9 | |
| SCHEMBL8476206 | 0.78 | SLC2A1 (0.68) | HTR2CHTR2AHTR2BCYP1A2 | |
| SCHEMBL7039444 | 0.78 | HTR2C (1.00) | HTR2CHTR2AHTR2BCYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014046544-A1 | SUBSTITUTED 3-HETEROARYLOXY-3-(HETERO)ARYL-PROPYLAMINES AS SEROTONIN TRANSPORTER AND SEROTONIN HT2C RECEPTOR MODULATORS | AAPA B.V. (NL) | 2014-03-27 | — | — | WO | disclosed |